SOME PHARMACOLOGICAL PROPERTIES OF A NEW ANTITUMOR DRUG, CPT-11, IN ISOLATED MUSCLE PREPARATIONS

被引：8
|
作者：
TAKAYANAGI, I
KOIKE, K
TAGAWA, M
MITSUHASHI, E
机构：
来源：
GENERAL PHARMACOLOGY | 1989年 / 20卷 / 06期
关键词：
D O I：
10.1016/0306-3623(89)90326-1
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：763 / 766
页数：4
相关论文
共 50 条
  • [1] PHARMACOLOGICAL CORRELATION BETWEEN TOTAL DRUG CONCENTRATION AND LACTONES OF CPT-11 AND SN-38 IN PATIENTS TREATED WITH CPT-11
    SASAKI, Y
    YOSHIDA, Y
    SUDOH, K
    HAKUSUI, H
    FUJII, H
    OHTSU, T
    WAKITA, H
    IGARASHI, T
    ITOH, K
    [J]. JAPANESE JOURNAL OF CANCER RESEARCH, 1995, 86 (01): : 111 - 116
  • [2] Identification of a new metabolite of CPT-11 (irinotecan): Pharmacological properties and activation to SN-38
    Dodds, HM
    Haaz, MC
    Riou, JF
    Robert, J
    Rivory, LP
    [J]. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 1998, 286 (01): : 578 - 583
  • [3] INTRACELLULAR ROLES OF SN-38, A METABOLITE OF THE CAMPTOTHECIN DERIVATIVE CPT-11, IN THE ANTITUMOR EFFECT OF CPT-11
    KAWATO, Y
    AONUMA, M
    HIROTA, Y
    KUGA, H
    SATO, K
    [J]. CANCER RESEARCH, 1991, 51 (16) : 4187 - 4191
  • [4] CPT-11:: A potential new chemotherapy drug for atypical or malignant meningioma
    Gupta, Vinay
    Su, Yuzhuang S.
    Samuelson, Christian G.
    Hofman, Florence M.
    Schönthal, Axel H.
    Chen, Thomas C.
    [J]. NEURO-ONCOLOGY, 2006, 8 (04) : 412 - 412
  • [5] ANTITUMOR EFFECT OF CPT-11, A NEW DERIVATIVE OF CAMPTOTHECIN, AGAINST PLEIOTROPIC DRUG-RESISTANT TUMORS INVITRO AND INVIVO
    TSURUO, T
    MATSUZAKI, T
    MATSUSHITA, M
    SAITO, H
    YOKOKURA, T
    [J]. CANCER CHEMOTHERAPY AND PHARMACOLOGY, 1988, 21 (01) : 71 - 74
  • [6] CPT-11 CONVERTING ENZYME FROM RAT SERUM - PURIFICATION AND SOME PROPERTIES
    TSUJI, T
    KANEDA, N
    KADO, K
    YOKOKURA, T
    YOSHIMOTO, T
    TSURU, D
    [J]. JOURNAL OF PHARMACOBIO-DYNAMICS, 1991, 14 (06): : 341 - 349
  • [7] EICOSANOID MEDIATED CL- SECRETION INDUCED BY THE ANTITUMOR DRUG, IRINOTECAN (CPT-11), IN THE RAT COLON
    SAKAI, H
    DIENER, M
    GARTMANN, V
    TAKEGUCHI, N
    [J]. NAUNYN-SCHMIEDEBERGS ARCHIVES OF PHARMACOLOGY, 1995, 351 (03) : 309 - 314
  • [8] Combination of novel sulfonamide anticancer drug, E7070, with CPT-11 "antitumor effect and synergistic mechanism"
    Ozawa, Y
    Kai, J
    Kusano, K
    Owa, T
    Yokoi, A
    Nagasu, T
    Asada, M
    Yoshimatsu, K
    [J]. EUROPEAN JOURNAL OF CANCER, 2002, 38 : S17 - S18
  • [9] Experimental antitumor activity and pharmacokinetics of the camptothecin analog irinotecan (CPT-11) in mice
    Bissery, MC
    Vrignaud, P
    Lavelle, F
    Chabot, GG
    [J]. ANTI-CANCER DRUGS, 1996, 7 (04) : 437 - 460
  • [10] Activation and antitumor activity of CPT-11 in plasma esterase-deficient mice
    Christopher L. Morton
    Lisa Iacono
    Janice L. Hyatt
    Kody R. Taylor
    Pamela J. Cheshire
    Peter J. Houghton
    Mary K. Danks
    Clinton F. Stewart
    Philip M. Potter
    [J]. Cancer Chemotherapy and Pharmacology, 2005, 56 : 629 - 636
12345